Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Fish and Richardson
Colorcon
US Army
Merck
Baxter
Queensland Health
AstraZeneca
UBS

Generated: June 18, 2018

DrugPatentWatch Database Preview

HOMAPIN-10 Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

When do Homapin-10 patents expire, and when can generic versions of Homapin-10 launch?

Homapin-10 is a drug marketed by Mission Pharma and is included in one NDA.

The generic ingredient in HOMAPIN-10 is homatropine methylbromide. There are five drug master file entries for this compound. Additional details are available on the homatropine methylbromide profile page.
Summary for HOMAPIN-10
Drug patent expirations by year for HOMAPIN-10
Synonyms for HOMAPIN-10
(1R,3S,5S)-3-[(2-hydroxy-2-phenylacetyl)oxy]-8,8-dimethyl-8-azabicyclo[3.2.1]octan-8-ium bromide
(8,8-dimethyl-8-azoniabicyclo[3.2.1]octan-3-yl) 2-hydroxy-2-phenyl-acetate bromide
(8,8-dimethyl-8-azoniabicyclo[3.2.1]octan-3-yl) 2-hydroxy-2-phenylacetate bromide
[(1S,5R)-8,8-dimethyl-8-azoniabicyclo[3.2.1]octan-3-yl] 2-oxidanyl-2-phenyl-ethanoate bromide
[(5S)-8,8-dimethyl-8-azoniabicyclo[3.2.1]octan-3-yl] 2-hydroxy-2-phenylacetate bromide
2-hydroxy-2-phenylacetic acid [(1S,5R)-8,8-dimethyl-8-azoniabicyclo[3.2.1]octan-3-yl] ester bromide
3-[(2-hydroxy-2-phenylacetyl)oxy]-8,8-dimethyl-8-azabicyclo[3.2.1]octan-8-ium bromide
3-[2-hydroxy(phenyl)acetoxy]-8,8-dimethyl-8-azoniabicyclo[3.2.1]octane bromide
3-{[hydroxy(phenyl)acetyl]oxy}-8,8-dimethyl-8-azoniabicyclo[3.2.1]octane bromide
3-alpha-Hydroxy-8-methyl-1-alpha-H,5-alpha-H-tropanium bromide mandelate
3alpha-Hydroxy-8-methyl-1alphaH,5alphaH-tropanium bromide mandelate
55198-66-8
58725-74-9
8-Azoniabicyclo(3.2.1)octane, 3-((2-hydroxy-2-phenylacetyl)oxy)-8,8-dimethyl-, bromide (1:1), (3-endo)-
8-Azoniabicyclo(3.2.1)octane, 3-((hydroxyphenylacetyl)oxy)-8,8-dimethyl-, bromide, (3-endo)-
8-Azoniabicyclo(3.2.1)octane, 3-((hydroxyphenylacetyl)oxy)-8,8-dimethyl-, bromide, endo-
8-Azoniabicyclo[3.2.1]octane, 3-[(2-hydroxy-2-phenylacetyl)oxy]-8,8-dimethyl-, bromide (1:1), (3-endo)-
8-Methylhomatropinium bromide
8,8-dimethyl-8-azabicyclo[3.2.1]oct-3-yl 2-hydroxy-2-phenylacetate, bromide
80-49-9
A839929
AC1L1MZP
AC1NWAN9
AC1Q1RH8
AK163175
AKOS015896228
AKOS025395549
AN-14686
API0000400
Arkitropin
Benzeneacetic acid, a-hydroxy-,(3-endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl ester
C16H21NO3.CH3Br
Camatropine
CCG-39581
CHEBI:50373
CHEMBL1200851
CS-5716
CTK5F7595
D02070
D0O5SZ
DB00725
DL-Homatropine methyl bromide
DL-Methylbromide
DR002033
DTXSID4023127
EINECS 201-284-0
Equipin
Equipin (TN)
Esopin
H-2560
HE097736
HE390602
HMS1920D15
HMS2091J21
HMS3652C19
HMS500G13
Homapin
Homapin-5
Homatromide
Homatropine (methylbromide)
Homatropine DL- methylbromide
Homatropine DL-methylbromide
Homatropine methobromide
Homatropine methyl bromide
homatropine methylbromide
Homatropine methylbromide (USP)
Homatropine methylbromide [INN:BAN]
Homatropine methylbromide [USP:INN:BAN]
homatropine methylbromide salt
HOMATROPINEMETHYLBROMIDE
Homatropini methylbromidum
Homatropini methylbromidum [INN-Latin]
HOMATROPINIUM, 8-METHYL-, BROMIDE
Humulon lead salt
HY-B1388
Hycodan, probilagol
I06-2047
KS-00001722
LS-75887
Malcotran
MCULE-4330080118
Mesopin
Methyl Bromide Homatropine
Methylbromure d'homatropine
Methylbromure d'homatropine [INN-French]
Methylhomatropine
Methylhomatropine bromide
Methylhomatropinum bromatum
Metilbromuro de homatropina
Metilbromuro de homatropina [INN-Spanish]
MFCD00050292
MolPort-023-219-684
MolPort-035-758-340
N-methylhomatropine bromide
N-Methylhomatropinium Bromide
NCGC00094694-01
NCGC00094694-02
Novatrin
Novatrine
Novatropine
Npvatropine
NSC 34399
NSC34399
Omatropina metilbromuro
Omatropina metilbromuro [DCIT]
S4024
SCHEMBL77827
Sed-Tems
Sethyl
SPECTRUM1500333
SR-05000002082
SR-05000002082-1
ST24047389
ST50993907
Tropinium methobromide mandelate

US Patents and Regulatory Information for HOMAPIN-10

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mission Pharma HOMAPIN-10 homatropine methylbromide TABLET;ORAL 086308-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
QuintilesIMS
Boehringer Ingelheim
Cantor Fitzgerald
Deloitte
Baxter
Citi
Argus Health
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.